T 0631/21 (Injectable hydrogel/BIOREGEN) of 25.07.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T063121.20230725
- Date of decision
- 25 July 2023
- Case number
- T 0631/21
- Petition for review of
- -
- Application number
- 09820182.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INJECTABLE IN-SITU CROSSLINKED HYDROGEL AND THE PREPARATION METHOD AND USE THEREOF
- Applicant name
- Bioregen Biomedical (Changzhou) Co., Ltd.
- Opponent name
- Croma-Pharma Gesellschaft m.b.H.
- Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Grounds for opposition - insufficiency of disclosure (no)
Novelty - prior disclosure
Novelty - implicit features (no)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is maintained as granted.